The firm plans to maintain its brands’ prestige positioning by judicious partnering with e-commerce distributors and a “digital-first mindset” that extends to the in-store experience. Lauder reports 9% sales growth for its latest quarter and 5% for its fiscal 2017, driven by double-digit gains in travel retail, online and specialty- and multi-channel retailers and from growth across geographies and categories except haircare.
The company-wide “digital-first” mindset [Estee Lauder Companies Inc.] is implementing will not diminish the value of traditional retail or dilute the prestige positioning of its brands, the firm is assuring investors.
CEO Fabrizio Freda says Lauder has no plans to begin distribution on Amazon, which he sees as non-conducive to the...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
